Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone and Pregabalin for Chronic Postsurgical Pain in Spinal Surgery
NCT05795478Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxycodone and pregabalin in chronic postsurgical pain (CPSP) (4 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of Chronic Postsurgical Pain at 3 months. Started Oct 2023; status: recruiting.
02
Drugs
oxycodonepregabalin
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT05795478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05795478.